Originally posted in Cystic Fibrosis News From Medical News Today

CARDIOLOGY: Abnormal heartbeats caused by changes in ion channel density Two independent studies have determined how changes in the density of different ion channels in the surface membrane of heart muscle cells can lead to life-threatening abnormal heartbeats.

Originally posted in Cystic Fibrosis News From Medical News Today

A cure for cystic fibrosis, HIV-fighting ‘Trojan horses’, new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field’s most prominent researchers will attend an international conference in Gothenburg, Sweden. In the field of chemical biology, chemists and biologists cooperate to investigate, and eventually control, the behavior of cells.

Originally posted in Cystic Fibrosis News From Medical News Today

A faster and cheaper way to find disease genes in the human genome that is being developed by researchers in the US has passed its initial “proof of concept” test by finding previously unknown gene mutations for Freeman-Sheldon syndrome, a rare Mendelian disorder, in unrelated affected individuals. Researchers from the University of Washington (UW) in Seattle wrote about their work in a paper that appears in the 16 August issue of Nature.

We’ve reached an exciting milestone in the search for a cure.

One of our most promising potential therapies, VX-770, is moving forward in clinical trials.

This compound has the potential to be one of the first drugs ever to treat the basic genetic defect in cystic fibrosis.

VX-770 (developed by Vertex Pharmaceuticals) is already being tested in adults. This week, for the first time, Vertex initiated a clinical trial in patients aged 6 to 11. Once the studies are complete, the FDA will determine if VX-770 is safe, effective and acceptable for approval.

To find out more about VX-770, read the full story and our FAQs. You can also read a very exciting article in today’s Xconomy, quoting CF researcher Bonnie Ramsey and highlighting the work of the Cystic Fibrosis Foundation.

This milestone would not be possible without your support, and we need your help now more than ever to make this drug a reality.

If you have CF, you can help by participating in the clinical trial. Learn more by calling the Vertex clinical trials hotline at (877) 634-8789.

You can also help support this and other lifesaving research by making a donation today.

Together we can make CF stand for “cure found.”

Originally posted in Cystic Fibrosis News From Medical News Today

Aradigm Corporation (OTCBB:ARDM) (the “Company”) announced yesterday that the European Medicines Agency (EMEA) granted Orphan Drug Designation to the Company’s inhaled liposomal ciprofloxacin drug product candidate for the treatment of lung infections associated with cystic fibrosis (“CF”).

European drug regulators have given Aradigm Corp. ‘s inhaled cystic fibrosis drug “orphan” status.

STX recently served as presenting sponsor for the “Swing for Charity event with Baltimore County Golf.” “Swing for Charity” was a free putting contest held during the Baltimore Orioles vs.

The U.S. Coast Guard estimates its “collective annual economic footprint” in the Mobile area at more than $65 million.

Christy L. Shaffer, who has been one of the Triangle’s most visible and passionate business leaders for more than a decade, plans to step down as CEO of Inspire Pharmaceuticals.